tradingkey.logo
tradingkey.logo
Search

Seres Therapeutics Inc

MCRB
Add to Watchlist
4.830USD
+0.050+1.05%
Close 07-31 16:00ETQuotes delayed by 15 min
46.33MMarket Cap
LossP/E TTM

MCRB Financials

See Seres Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Seres Therapeutics Inc Earnings Date

Latest Release
May 5, 2026
EPS / Forecast
-2.08/-1.88
Revenue / Forecast
358.00K/--
Period
FY2025 Earnings
Revenue(YoY)
789.00K
--
EPS(YoY)
0.64
3553.18%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-102.77%-2.08
8.99%-1.66
-91.95%0.94
47.67%-2.27
1467.03%75.10
71.21%-1.83
255.91%11.63
-159.52%-4.34
51.42%-5.49
42.33%-6.34
---7.46
--7.29
---11.31
---10.99
---35.43
----
----
----
----
----
Revenue
--358.00K
--438.00K
--351.00K
----
----
----
-100.00%0.00
-100.00%0.00
100.00%0.00
-93.44%64.00K
-91.00%310.00K
10300.74%126.47M
-134.96%-522.00K
-86.50%975.00K
-97.28%3.44M
-76.90%1.22M
-73.89%1.49M
-58.89%7.22M
8843.19%126.72M
-12.94%5.26M
Net Profit
-160.93%-19.91M
1.93%-15.34M
-90.76%8.20M
39.60%-19.86M
181.43%32.68M
62.09%-15.64M
285.51%88.78M
-170.61%-32.87M
43.61%-40.13M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-37.59%-68.80M
-187.96%-60.00M
-33.94%-64.73M
-59.66%-56.62M
-173.95%-50.00M
325.29%68.22M
-133.32%-48.33M
Net Margin
---5562.29%
---3501.14%
--2337.32%
----
----
----
----
----
----
----
----
--36.81%
----
----
---2947.52%
----
----
----
----
----
Gross Margin
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
--100.00%
----
----
--100.00%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
-100.00%0.00%
-100.00%0.00%
28.51%31.86%
57.64%29.89%
93.48%28.32%
--27.50%
--24.79%
--18.96%
--14.64%
--16.31%
----
----
----
----
----
Revenue
--358.00K
--438.00K
--351.00K
----
----
----
-100.00%0.00
-100.00%0.00
100.00%0.00
-93.44%64.00K
-91.00%310.00K
10300.74%126.47M
-134.96%-522.00K
-86.50%975.00K
-97.28%3.44M
-76.90%1.22M
-73.89%1.49M
-58.89%7.22M
8843.19%126.72M
-12.94%5.26M
Operating profit
23.24%-20.91M
36.36%-18.35M
22.94%-22.48M
20.62%-24.88M
10.93%-27.24M
22.12%-28.84M
34.58%-29.17M
-163.29%-31.34M
56.67%-30.58M
-2038.88%-37.02M
24.57%-44.59M
178.21%49.52M
-26.58%-70.57M
96.50%-1.73M
-186.40%-59.11M
-31.54%-63.33M
-57.82%-55.75M
-176.19%-49.43M
328.06%68.41M
-134.32%-48.14M
Net Profit
-160.93%-19.91M
1.93%-15.34M
-90.76%8.20M
39.60%-19.86M
181.43%32.68M
62.09%-15.64M
285.51%88.78M
-170.61%-32.87M
43.61%-40.13M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-37.59%-68.80M
-187.96%-60.00M
-33.94%-64.73M
-59.66%-56.62M
-173.95%-50.00M
325.29%68.22M
-133.32%-48.33M
Current assets
-51.82%31.84M
27.67%49.38M
-29.35%51.53M
-67.38%48.69M
-60.00%66.08M
-77.95%38.67M
-65.98%72.93M
-40.59%149.26M
42.30%165.18M
-9.94%175.41M
-13.38%214.39M
19.88%251.24M
-55.90%116.08M
-35.85%194.76M
-31.02%247.51M
-6.67%209.58M
4.47%263.25M
12.97%303.63M
16.49%358.81M
208.81%224.56M
Total current liabilities
-38.24%19.34M
-53.13%19.32M
-65.40%22.43M
-71.43%30.94M
-68.19%31.32M
-58.22%41.22M
-18.17%64.83M
39.00%108.28M
54.31%98.48M
15.26%98.66M
-3.17%79.22M
-12.51%77.90M
-22.51%63.82M
4.06%85.60M
-13.50%81.82M
58.53%89.04M
72.07%82.36M
77.22%82.26M
106.67%94.59M
26.93%56.16M
Total assets
-28.36%117.62M
-1.16%138.19M
-19.73%143.47M
-55.30%143.80M
-51.89%164.18M
-61.01%139.81M
-51.39%178.74M
-20.83%321.73M
26.30%341.26M
2.81%358.60M
17.90%367.70M
48.75%406.39M
-15.54%270.19M
-1.71%348.78M
-21.30%311.87M
1.32%273.20M
4.64%319.89M
3.48%354.86M
11.26%396.29M
167.83%269.65M
Total liabilities
-19.87%91.12M
-25.43%93.97M
-35.55%99.78M
-72.88%110.85M
-71.64%113.72M
-68.76%126.03M
-59.56%154.82M
6.52%408.81M
26.07%401.00M
19.37%403.46M
56.71%382.82M
53.42%383.77M
33.12%318.06M
51.33%338.00M
10.76%244.28M
48.38%250.14M
47.50%238.93M
32.80%223.35M
31.17%220.56M
1.40%168.58M
Total equity
-47.49%26.50M
220.79%44.22M
82.69%43.70M
137.84%32.95M
184.48%50.47M
130.73%13.78M
258.16%23.92M
-485.04%-87.07M
-24.79%-59.74M
-515.99%-44.86M
-122.38%-15.12M
-1.93%22.61M
-159.13%-47.87M
-91.80%10.78M
-61.54%67.58M
-77.19%23.06M
-43.67%80.96M
-24.75%131.51M
-6.55%175.74M
254.12%101.07M
Net operating income
-160.80%-16.36M
62.17%-14.71M
106.36%2.21M
66.62%-13.29M
176.37%26.91M
18.14%-38.88M
41.47%-34.68M
-160.34%-39.81M
53.99%-35.24M
10.20%-47.50M
0.55%-59.26M
232.24%65.98M
-15.26%-76.58M
-1.99%-52.89M
-146.64%-59.58M
-25.70%-49.90M
-125.27%-66.44M
-189.30%-51.86M
593.86%127.74M
-55.26%-39.70M
Net investment
100.00%0.00
301.11%181.00K
-100.01%-8.00K
-113.90%-181.00K
45.16%-34.00K
89.74%-90.00K
7954.37%141.14M
-87.62%1.30M
-102.26%-62.00K
-114.80%-877.00K
-104.48%-1.80M
-55.05%10.52M
-78.89%2.74M
-55.06%5.93M
59.81%40.13M
-49.71%23.40M
162.55%12.97M
117.50%13.19M
122.70%25.11M
163.60%46.53M
Net financing
-63.73%428.00K
628.67%12.66M
100.06%61.00K
--0.00
-93.71%1.18M
-72.98%1.74M
-7783.37%-110.87M
-100.00%0.00
231.72%18.76M
39.85%6.43M
-98.53%1.44M
44651.54%58.18M
-78.93%5.66M
689.36%4.60M
15996.39%98.03M
-77.78%130.00K
3414.14%26.85M
-139.29%-780.00K
-99.78%609.00K
-95.99%585.00K

FAQs

What is the total revenue of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its total revenue reached 789.00K, with a year-on-year change of 789.00K.

What are the current assets of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its current assets were 49.38M, with a year-on-year change of 27.67.

What are the total assets of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its total assets of Seres Therapeutics Inc were 138.19M, with a year-on-year change of -1.16.

What are the total liabilities of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its total liabilities of Seres Therapeutics Inc were 93.97M, with a year-on-year change of -25.43.

What is the total equity of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its total equity of Seres Therapeutics Inc was 44.22M, with a year-on-year change of 220.79.

What is the net operating income of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its net operating income of Seres Therapeutics Inc was -92.94M, with a year-on-year change of 19.40.

What is the net investment of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its net investment of Seres Therapeutics Inc was -42.00K, with a year-on-year change of -100.03.

What is the net financing of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its net financing of Seres Therapeutics Inc was 13.90M, with a year-on-year change of 115.38.

What is the Earnings Per Share (EPS) of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.64, with a year-on-year change of 3553.18.

What is the net income of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its net income was 5.70M, with a year-on-year change of 4088.24.

What is the Return on Assets (ROA) of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 4.10, with a year-on-year change of 108.12.

What is the operating profit of Seres Therapeutics Inc?

According to Seres Therapeutics Inc's FY2025 earnings report, its operating profit was -92.94M, with a year-on-year change of 19.40.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.